Facebook Twitter Instagram WhatsApp
    Trending
    • Goa might ban some aggressive dog breeds
    • 3,921 heart attack cases diagnosed, 2,948 patients thrombolised through STEMI project in last 5 yrs
    • High Court quashes govt’s decision to short charge Sunburn organisers
    • FDA directed to crack down on food business operators violating food safety norms
    • UP native arrested for house breaking theft in Revora
    • PWD to appoint 2 contractors to oversee speed breaker works across Goa: Cabral
    • CM accepts shack operators formula for shack allocation
    • Govt issues draft notification declaring 7 lakes across Goa as wetlands
    Login
    Saturday, September 30
    Goemkarponn – Goa NewsGoemkarponn – Goa News
    Facebook Twitter Instagram
    ePaper
    • Home
    • Goa News
    • Business
    • Political News
    • Local News
    • Goemkar Special
    • Travel
    • More
      • Top News
      • Sports
      • Page 3
      • Crime
      • Snippets
      • Cricket
      • Football
      • Health
      • Off Beat
    • Video News
    • About Us
    • Contact Us
    Goemkarponn – Goa NewsGoemkarponn – Goa News
    Home»Goa News

    Everyone above the age of 18 to be eligible to get vaccine against Covid-19 from May 1: Centre

    adminBy adminApril 19, 2021Updated:August 12, 2022 Goa News No Comments6 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Goemkarponn Desk

    DELHI: In a meeting chaired by PM Narendra Modi, an important decision of allowing vaccination to everyone above the age of 18 from 1st May has been taken. PM said that the Government has been working hard from over a year to ensure that maximum numbers of Indians are able to get the vaccine in the shortest possible of time. He added that India is vaccinating people at world record pace& we will continue this with even greater momentum.

    India’s National Covid-19 Vaccination Strategy has been built on a systematic and strategic end-to-end approach, proactively building capacity across R&D, Manufacturing and Administration since April 2020. While pushing for scale and speed, it has simultaneously been anchored in the stability necessary to sustainably execute the World’s Largest Vaccination Drive.

    India’s approach has been built on scientific and epidemiological pillars, guided by Global Best Practices, SoPs of WHO as well as our India’s foremost experts in the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC).

    India has been following a dynamic mapping model based on availability of vaccines & coverage of vulnerable priority groups to take decisions of when to open up vaccinations to other age-groups. A good amount of coverage of vulnerable groups is expected by 30th April.

    Phase-I of the National Covid-19 Vaccination Strategy was launched on 16th January 2021, prioritizing protection for our protectors, our Health Care Workers (HCWs) and Front Line Workers (FLWs). As systems and processes stabilized, Phase-II was initiated from 1st March 2021, focusing on protecting our most vulnerable i.e. all people above 45 years of age, accounting for more than 80% Covid mortality in the country. The private sector was also roped in to augment capacity.

    As per PM Modi’s directions, Government of India has proactively engaged and coordinated with stakeholders across the spectrum, from research institutes to national and international manufacturers, global regulators etc. The strength of India’s private sector vaccine manufacturing capability has been strategically empowered through unprecedented decisive steps, from facilitating public-private collaborative research, trials and product development, to targeted public grants and far-reaching governance reforms in India’s regulatory system. Government of According to PM Modi’s instructions, India is in regular touch with each manufacturer, including having sent multiple inter-ministerial teams on site, to understand each one’s requirements and provide proactive and customized support in the form of grants, advance payments, more sites for production, etc to ramp up vaccine production.

    This has resulted in Emergency Use Authorisation being granted to two indigenously manufactured vaccines (Serum Institute of India and Bharat Biotech), and a third vaccine (Sputnik) that while presently manufactured abroad will eventually be manufactured in India.

    Government of India has roped in the private sector in the vaccination drive right from the beginning. Now, as capabilities and processes have stabilized, the public as well as private sector has the experience and confidence to rapidly scale up.

    In its Phase-III, the National Vaccine Strategy aims at liberalised vaccine pricing and scaling up of vaccine coverage. This would augment vaccine production as well as availability, incentivising vaccine manufacturers to rapidly ramp up their production as well as attract new vaccine manufacturers, domestic and international. It would also make pricing, procurement, eligibility and administration of vaccines open and flexible, allowing all stakeholders the flexibility to customise to local needs and dynamics.

    The main elements of the  Liberalised and Accelerated Phase 3 Strategy of the National Covid-19 Vaccination program that would come in effect from 1st May 2021, are as follows:-

    (i)      Vaccine manufacturers would supply 50% of their monthly Central Drugs Laboratory (CDL) released doses to Govt. of India and would be free to supply the remaining 50% doses to State Govts. and in the open market (hereinafter referred to as other than Govt. of India channel).

    (ii)    Manufacturers would transparently make an advance declaration of the price for 50% supply that would be available to State Govts. and in open market, before 1st May 2021. Based on this price, State governments, private hospitals, industrial establishments etc would be able to procure vaccine doses from the manufacturers. Private Hospitals would have to procure their supplies of Covid-19 vaccine exclusively from the 50% supply earmarked for other than Govt. of India channel. Private Vaccination providers shall transparently declare their self-set vaccination price. The eligibility through this channel would be opened up to all adults, i.e. everyone above the age of 18.

    (iii)    Vaccination shall continue as before in Govt. of India vaccination centres, provided free of cost to the eligible population as defined earlier i.e. Health Care Workers (HCWs), Front Line Workers (FLWs) and all people above 45 years of age.

    (iv)    All vaccination (through Govt. of India and Other than Govt. of India channel) would be part of the National Vaccination Programme, and mandated to follow all protocol such as being captured on CoWIN platform, linked to AEFI reporting and all other prescribed norms. Stocks and price per vaccination applicable in all vaccination centres will also have to be reported real-time.

    (v)     The division of vaccine supply 50% to Govt. of India and 50% to other than Govt. of India channel would be applicable uniformly across for all vaccines manufactured in the country. However Government of India will allow the imported fully ready to use vaccines to be entirely utilized in the other than Govt. of India channel.

    (vi)    Govt. of India, from its share, will allocate vaccines to States/UTs based on the criteria of extent of infection (number of active Covid cases) & performance (speed of administration). Wastage of vaccine will also be considered in this criteria and will affect the criteria negatively. Based on the above criteria, State-wise quota would be decided and communicated to the States adequately in advance.

    (vii) Second dose of all existing priority groups i.e. HCWs, FLWs and population above 45 years, wherever it has become due, would be given priority, for which a specific and focused strategy would be communicated to all stakeholders.

    (viii) This policy would come into effect from 1st May 2021 and will be reviewed from time to time.

    Comment

    admin

    Keep Reading

    In Delhi, US President Joe Biden Performs Holy Communion With Goa Priest Before The G20 Summit

    “Leaking” Ponda Market Complex causes hardship to Visitors

    Mopa Link Road Accident: Goa Cong Demand FIR against contractor Ashoka Buildcon

    Centre spent Rs 30,000 crore on Goa’s development: CM Sawant

    Goa Forward Chief Opposes Private Medical  College at SGDH, Wants AIIMS Instead 

    I Want The People of Goa To Know That RP-21  Was A BIG SCAM: Goa TCP Minister

    Add A Comment

    Comments are closed.

    Archives
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    Categories
    • Big Story
    • Business News
    • Cricket
    • Crime
    • Football
    • Goa News
    • Goemkar Special
    • Health
    • India News
    • Local News
    • Off Beat
    • Opinion
    • Page 3
    • Photos
    • Political News
    • Snippets
    • Sports
    • Top News
    • Travel
    • Trending
    • Videos
    About
    About

    The Goemkarponn digital media platform gives you the latest news of the Goa Region. To read Goemkarponn News on your mobile, download our Android App (Goemkarponn News App).

    Facebook Twitter Instagram Pinterest YouTube WhatsApp
    LINKS
    • Local News
    • Goa News
    • Political News
    • Goemkar Special
    ADVERTISEMENT
    AVAILABLE AD BANNER
    • About Us
    • Contact Us
    Goemkarponn © 2023 - Powered by Xperts!.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Do not sell my personal information.
    Cookie SettingsAccept
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?